Download MBBS Dermatology PPT 1 Pbl Papulosquamous Diseases Lecture Notes

Download MBBS (Bachelor of Medicine, Bachelor of Surgery) Dermatology PPT 1 Pbl Papulosquamous Diseases Lecture Notes


PBL ? Papulosquamous

Diseases

The Problem

? A 50-year-old male patient
? Presents with a history of skin lesions x 34 years
? Red, itchy, scaly, lesions present all over the body & head
? Lesions increase in summer but improve in winter
? No joint pains
? On clinical examination: BSA: 15% apprx.; Erythematous, scaly,

sharply demarcated, plaques, present particularly over the extensor

surfaces & scalp

? Palms & soles: largely spared


D/D & D
? Type 1 hereditary, strongly HLA associated (particularly HLACw6),

early onset & more likely to be severe

? Type 2 sporadic, HLA unrelated, of late onset & often mild

How to Quantify involvement


PASI

? PASI ? 10
? Moderate
Tests / Sign

? Grattage test - Scales in a psoriatic plaque can be accentuated by

grating with a glass slide

? Auspitz sign- 3 steps
? Step A: Gently scrape lesion with a glass slide - This accentuates the

silvery scales (Grattage test positive). Scrape off all the scales

? Step B: Continue to scrape the lesion ? A glistening white adherent

membrane (Burkley's membrane) appears

? Step C: On removing the membrane, punctate bleeding points

become visible - positive Auspitz sign
How to treat this patient

? Systemic antibiotics in psoriasis
? Anti-Streptococcus medications ? may clear guttate attacks

? Diet in Psoriasis
? No clear evidence for / against oral zinc, fish oils, omega-3 fatty acids,

turkey meat or diets low in tryptophan, protein or calories

? Some studies demonstrate celiac diseases associated-antibodies ?

elimination of wheat from diet may bring long-term remissions

? Treatment options



Topical therapy

? Emollients - prevent & treat xerosis, decrease scaling

? Moisturizing agents - cream bases, coconut / olive oil, white soft

paraffin & liquid paraffin mixtures etc.
Investigations

? Systemic therapy
? Why

? Initiation of systemic therapy - a shared decision between the patient

& the clinician

? Careful consideration of risk?benefit profiles of available treatments
? In general, systemic treatment indicated for - extensive disease not

responsive to topical therapy or phototherapy; erythroderma;

pustular psoriasis; psoriatic arthritis

? Impact of disease ? patient may opt for earlier systemic treatment
? Logistics - e.g., inability to attend for regular phototherapy
? Investigations:
? CBCs with ESR & PBF
? LFTs, RFTs, FBS/RBS, HBA1c, Urine R/E, M/E
? HBsAg, HCV, HIV-1 & 2
? CXR-PA
? Other investigations

Systemic Steroids
? When systemic steroid is given for 1st time, clearance of psoriasis is

rapid but the disease eventually `breaks through', necessitating

progressive increases in dosage, with incidence of side effects

? If withdrawal is attempted, psoriasis tends to relapse promptly & may

`rebound'

? `Rebound' may take the form of widespread, eruptive psoriasis,

erythrodermic psoriasis or generalized pustular psoriasis

? Systemic steroids should NEVER be used in the routine care of

psoriasis

? Psoriasis may remain labile & treatment resistant for many months

after the withdrawal
? Oral or parenteral corticosteroids should generally be avoided

? Used only when urgent control of complications is needed (e.g., acute

respiratory distress syndrome)

? Or when other drugs are contraindicated for instance in pregnancy

? Shortterm effects of prednisolone (30?40 mg/day) may be good but

serious relapses are liable to occur as the dosage is reduced unless

another form of therapy (e.g., acitretin, TNFi) is given simultaneously

Counselling
? Psoriasis ? a treatable but incurable disease
? `Psoriasis is at all times and under all forms a very troublesome and,

often, an intractable disease, but it is rarely dangerous to life'?

Wilson, 1842

? `It is impossible to say, in any particular case, how long the disease

will last, whether a relapse will occur, or for what period of time the

patient will remain free from psoriasis'? Hebra, 1868

? Patients' counseling ? paramount

Papulosquamous Diseases

? Psoriasis
? Pityriasis rosea
? Lichen planus
? Erythroderma
? Pityriasis lichenoides
? Pityriasis rubra pilaris
? Parapsoriasis
Erythroderma

? Erythroderma is a morphological diagnosis characterized by

generalized erythema and scaling

? Diffuse erythema and scaling of the skin involving more than 90% of

the total body skin surface area

? Erythroderma is the term applied to any inflammatory skin disease

that affects more than 90% of the body surface

Thank You

This post was last modified on 07 April 2022